221 related articles for article (PubMed ID: 17321295)
41. [Future scenarios of HIV-AIDS: from the "event" disease to diffuse chronicity. From the moral stigma to the central zones of social vulnerability].
Conde Gutiérrez F
Rev Esp Salud Publica; 1997; 71(1):1-7. PubMed ID: 9147793
[No Abstract] [Full Text] [Related]
42. [The characteristics of the epidemic process of HIV infection in the Armed Forces].
Zmushko EI; Bolekhan VN; Borzykh VA
Voen Med Zh; 1998 Aug; 319(8):44-7. PubMed ID: 9793449
[No Abstract] [Full Text] [Related]
43. Late for the epidemic: HIV/AIDS in Eastern Europe.
Cohen J
Science; 2010 Jul; 329(5988):160, 162-4. PubMed ID: 20616262
[No Abstract] [Full Text] [Related]
44. HIV and related risk behavior among men who have sex with men in Zanzibar, Tanzania: results of a behavioral surveillance survey.
Dahoma M; Johnston LG; Holman A; Miller LA; Mussa M; Othman A; Khatib A; Issa R; Kendall C; Kim AA
AIDS Behav; 2011 Jan; 15(1):186-92. PubMed ID: 19997862
[TBL] [Abstract][Full Text] [Related]
45. A revised strategy for HIV and AIDS health promotion.
Commun Dis Rep CDR Wkly; 1995 Dec; 5(48):263. PubMed ID: 8547969
[No Abstract] [Full Text] [Related]
46. Drug use and HIV risk among gay and bisexual men: an overview.
Battjes RJ
NIDA Res Monogr; 1994; 143():82-7. PubMed ID: 8742593
[No Abstract] [Full Text] [Related]
47. Epidemiology and the human immunodeficiency virus. Clinical effects of intravenous drug misuse.
Volberding PA
JAMA; 1992 Mar; 267(12):1666-7. PubMed ID: 1542178
[No Abstract] [Full Text] [Related]
48. New York, New York. Miracle on 34th Street: success with injectors.
Cohen J
Science; 2012 Jul; 337(6091):178-80. PubMed ID: 22798601
[No Abstract] [Full Text] [Related]
49. Determinants of HIV risk among men who have homosexual sex and inject drugs.
Crofts N; Marcus L; Meade J; Sattler G; Wallace J; Sharp R
AIDS Care; 1995; 7(5):647-55. PubMed ID: 8652699
[TBL] [Abstract][Full Text] [Related]
50. Washington, District of Columbia. HIV/AIDS response renovated in capital.
Cohen J
Science; 2012 Jul; 337(6091):182. PubMed ID: 22798605
[No Abstract] [Full Text] [Related]
51. Phylogenetic Insights on Patterns of HIV-1 Spread and the Design of Epidemic Control Measures.
Brenner BG
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215925
[TBL] [Abstract][Full Text] [Related]
52. HIV-1 CRF07_BC infections, injecting drug users, Taiwan.
Chen YM; Lan YC; Lai SF; Yang JY; Tsai SF; Kuo SH
Emerg Infect Dis; 2006 Apr; 12(4):703-5. PubMed ID: 16715583
[No Abstract] [Full Text] [Related]
53. Public health versus political frontiers.
The Lancet
Lancet; 2007 Feb; 369(9562):616. PubMed ID: 17321291
[No Abstract] [Full Text] [Related]
54. HIV/AIDS harm reduction in Iran.
Razzaghi E; Nassirimanesh B; Afshar P; Ohiri K; Claeson M; Power R
Lancet; 2006 Aug; 368(9534):434-5. PubMed ID: 16890814
[No Abstract] [Full Text] [Related]
55. Differences between the course of the drug addict's HIV infection and that of other HIV-infected patients.
Gölz J
Forensic Sci Int; 1993 Nov; 62(1-2):95-9. PubMed ID: 8300042
[TBL] [Abstract][Full Text] [Related]
56. AIDS. Asia grapples with unexpected wave of HIV infections.
Normile D
Science; 2009 Nov; 326(5957):1174. PubMed ID: 19965441
[No Abstract] [Full Text] [Related]
57. HIV among drug users in China.
Feng C; Des Jarlais D
Science; 2002 Nov; 298(5596):1171; author reply 1171. PubMed ID: 12425324
[No Abstract] [Full Text] [Related]
58. [Emergency measures to control the spread of diseases caused by the human immunodeficiency virus].
Onishchenko GG; Beklemishcheva OA; Narkevich MI
Zh Mikrobiol Epidemiol Immunobiol; 1999; (1):5-9. PubMed ID: 10096182
[TBL] [Abstract][Full Text] [Related]
59. [Hemiparesis-ataxia in an HIV-positive man].
Días Silva JJ; Martínez Muñiz A; Pedreira Andrade JD
Rev Clin Esp; 1995 Sep; 195(9):663-4. PubMed ID: 7481015
[No Abstract] [Full Text] [Related]
60. HIV/AIDS in prisons.
McKee KJ; Power KG
Scott Med J; 1992 Oct; 37(5):132-7. PubMed ID: 1492203
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
